rs57932685

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS1

The NM_001173990.3(TMEM216):​c.211G>T​(p.Val71Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000418 in 1,613,992 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 1 hom. )

Consequence

TMEM216
NM_001173990.3 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.427
Variant links:
Genes affected
TMEM216 (HGNC:25018): (transmembrane protein 216) This locus encodes a transmembrane domain-containing protein. Mutations at this locus have been associated with Meckel-Gruber Syndrome Type 2, and Joubert Syndrome 2, also known as Cerebello-oculorenal Syndrome 2. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM1
In a transmembrane_region Helical (size 20) in uniprot entity TM216_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_001173990.3
BP4
Computational evidence support a benign effect (MetaRNN=0.007510036).
BP6
Variant 11-61393958-G-T is Benign according to our data. Variant chr11-61393958-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 196320.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00228 (348/152312) while in subpopulation AFR AF= 0.00789 (328/41566). AF 95% confidence interval is 0.00719. There are 1 homozygotes in gnomad4. There are 152 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM216NM_001173990.3 linkc.211G>T p.Val71Leu missense_variant Exon 3 of 5 ENST00000515837.7 NP_001167461.1 Q9P0N5-1
TMEM216NM_001173991.3 linkc.211G>T p.Val71Leu missense_variant Exon 3 of 5 NP_001167462.1 Q9P0N5-3
TMEM216NM_016499.6 linkc.28G>T p.Val10Leu missense_variant Exon 3 of 5 NP_057583.2 Q9P0N5-2
TMEM216NM_001330285.2 linkc.28G>T p.Val10Leu missense_variant Exon 3 of 5 NP_001317214.1 Q9P0N5J3QT25

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM216ENST00000515837.7 linkc.211G>T p.Val71Leu missense_variant Exon 3 of 5 2 NM_001173990.3 ENSP00000440638.1 Q9P0N5-1
TMEM216ENST00000334888.10 linkc.211G>T p.Val71Leu missense_variant Exon 3 of 5 2 ENSP00000334844.5 Q9P0N5-3

Frequencies

GnomAD3 genomes
AF:
0.00229
AC:
348
AN:
152194
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00791
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000917
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000542
AC:
135
AN:
249236
Hom.:
0
AF XY:
0.000422
AC XY:
57
AN XY:
135218
show subpopulations
Gnomad AFR exome
AF:
0.00788
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000334
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000224
AC:
327
AN:
1461680
Hom.:
1
Cov.:
30
AF XY:
0.000179
AC XY:
130
AN XY:
727120
show subpopulations
Gnomad4 AFR exome
AF:
0.00845
Gnomad4 AMR exome
AF:
0.000268
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000540
Gnomad4 OTH exome
AF:
0.000381
GnomAD4 genome
AF:
0.00228
AC:
348
AN:
152312
Hom.:
1
Cov.:
32
AF XY:
0.00204
AC XY:
152
AN XY:
74486
show subpopulations
Gnomad4 AFR
AF:
0.00789
Gnomad4 AMR
AF:
0.000916
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000493
Hom.:
1
Bravo
AF:
0.00247
ESP6500AA
AF:
0.00801
AC:
31
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000604
AC:
73
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:2
Jan 14, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 24, 2017
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The V71L variant has been previously reported as a benign polymorphism which showed stable expression of the protein similar to wild type expression (Valente et al., 2010). This variant is observed in 70/9798 (0.7%) alleles from individuals of African background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The V71L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Valine are tolerated across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Additionally, missense variants in a nearby residue (R73C/H/L) have been reported in Human Gene Mutation Database in association with Joubert syndrome (Stenson et al., 2014). Based on the currently available information, it is unclear whether the V71L variant is a pathogenic variant or a rare benign variant. -

Familial aplasia of the vermis Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Joubert syndrome 2 Benign:1
Jul 17, 2020
Natera, Inc.
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.40
T;.;.
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.85
D;D;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.0075
T;T;T
MetaSVM
Benign
-0.68
T
MutationAssessor
Benign
0.95
L;L;.
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.19
Sift
Benign
0.098
T;T;T
Sift4G
Benign
0.85
T;T;T
Vest4
0.20
MVP
0.51
MPC
0.13
ClinPred
0.0070
T
GERP RS
2.7
Varity_R
0.093
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs57932685; hg19: chr11-61161430; API